Market Place
Sourcing Support
Innocan Pharma Reports Positive Safety Results with LPT-CBD
26 Nov 2024 //
PR NEWSWIRE
Innocan Pharma Reports Third Quarter 2024 Financial Results
20 Nov 2024 //
PR NEWSWIRE
Innocan Focuses on Positive FDA Engagement & Market Potential
11 Nov 2024 //
PR NEWSWIRE
Innocan Pharma to Present at the 2024 ThinkEquity Conference
21 Oct 2024 //
GLOBENEWSWIRE
Innocan Pharma Joins ThinkEquity 2024 Investor Conference
16 Oct 2024 //
PR NEWSWIRE
Innocan`s LPT-CBD Shows Success in Osteoarthritis Pain in Dogs
11 Oct 2024 //
PR NEWSWIRE
Innocan Pharma Celebrates Dr. Joseph Pergolizzi`s Recognition
09 Oct 2024 //
PR NEWSWIRE
Innocan Pharma Advances Liposomal CBD with Positive Response from FDA
03 Sep 2024 //
PR NEWSWIRE
Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options
29 Aug 2024 //
PR NEWSWIRE
Innocan Pharma`s Subsidiary Completes FDA MoCRA Registration
22 Aug 2024 //
PR NEWSWIRE
Innocan Pharma Q2 2024 Revenue Grows 2.8X To $8.6 Million
12 Aug 2024 //
PR NEWSWIRE
Innocan Pharma Files FDA Application For New Veterinary Drug
26 Jul 2024 //
PR NEWSWIRE
Innocan Pharma Engages Pain Expert For Upcoming FDA Meeting
02 Jul 2024 //
PR NEWSWIRE
Innocan Pharma Announces Successful LPT-CBD Safety In Minipigs
11 Jun 2024 //
PR NEWSWIRE
Innocan Q1 2024 Revenue Growth: Over 4X Increase To $6.8M Reported
27 May 2024 //
PR NEWSWIRE
FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain
21 May 2024 //
PR NEWSWIRE
Innocan Initiates FDA Approval For Liposome Pain Injection
22 Apr 2024 //
PR NEWSWIRE
Innocan Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M
01 Apr 2024 //
PR NEWSWIRE
Innocan Pharma paves its way to LPT-CBD CMC key milestones for FDA approval
25 Mar 2024 //
PR NEWSWIRE
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds
14 Mar 2024 //
PR NEWSWIRE
Innocan Pharma`s LPT-CBD Has the Potential to Support a new Therapeutic Venue
05 Mar 2024 //
PR NEWSWIRE
Innocan Announces Study Findings that LPT-CBD maintains release in Rabbits
26 Feb 2024 //
PR NEWSWIRE
Innocan Pharma to provide a corporate update via Zoom livestream
05 Feb 2024 //
PR NEWSWIRE
Innocan Pharma Announces Expert Team for LPT CBD Application to FDA
12 Dec 2023 //
PR NEWSWIRE
Innocan Pharma Announces Promising LPT-CBD Safety Indications -Implications
03 Nov 2023 //
PR NEWSWIRE
Innocan reports discovery regarding its LPD platform and global CBD research
25 Oct 2023 //
INDIAN PHARMA POST
Innocan Pharma reports a groundbreaking discovery regarding its LPD platform
23 Oct 2023 //
PR NEWSWIRE
Innocan Pharma Announces Closing of Second and Final Tranche of Financing
20 Oct 2023 //
PR NEWSWIRE
Innocan Pharma Announces Closing of First Tranche Private Placement
12 Oct 2023 //
PR NEWSWIRE
Innocan Pharma Announces Brokered LIFE Offering of Units for Up to $3 Million
21 Sep 2023 //
GLOBENEWSWIRE
Innocan Announces the Addition of Dr. Joseph V. Pergolizzi to Advisory Board
15 Sep 2023 //
PR NEWSWIRE
Innocan Pharma Announces Promising Results from Hair Care Cream Efficacy Test
05 Sep 2023 //
PR NEWSWIRE
Innocan Pharma Reports Q2 2023 Results
25 Aug 2023 //
PR NEWSWIRE
Innocan Announces Private Placement of Units at a 9% Prime Above Share Price
25 Jul 2023 //
PR NEWSWIRE
Innocan Pharma Unveils Groundbreaking Veterinary Breakthroughs at EAVPT 2023
22 Jun 2023 //
PR NEWSWIRE
InnoCan submits new patent applications for advanced pain relief technology
13 Jun 2023 //
INDIAN PHARMA PSOT
InnoCan Pharma Submits Patent Applications for Advanced Pain Relief Technology
12 Jun 2023 //
PR NEWSWIRE
Innocan Pharma Reports Q1 2023 Results
31 May 2023 //
PR NEWSWIRE
Innocan Pharma Reports Success in a Pre-Clinical Trial of a Liposomal-CBD Inj
08 May 2023 //
PR NEWSWIRE
Innocan Pharma announces expansion to Lithuania, Latvia & Estonia markets
03 May 2023 //
INDIANPHARMAPOST
Innocan Pharma Reports Annual 2022 Results with USD 2.6M in Revenue
18 Apr 2023 //
PR NEWSWIRE
Innocan Reports Novel Cannabinoid Delivery Platform Patent Application
03 Apr 2023 //
PR NEWSWIRE
The Future Markets Research Releases Market Commentary on Innocan Pharma
28 Mar 2022 //
BUSINESSWIRE
Innocan Pharma highlights data from CBD-loaded liposome technology animal study
03 Sep 2021 //
SEEKINGALPHA
Innocan Pharma Corporation to Webcast Live at Life Sciences Investor Forum
21 Jun 2021 //
GLOBENEWSWIRE
